Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

Thomas A. Zelniker, Stephen D. Wiviott, Itamar Raz, Kyung Ah Im, Erica L. Goodrich, Remo H.M. Furtado, Marc P. Bonaca, Ofri Mosenzon, Eri T. Kato, Avivit Cahn, Deepak L. Bhatt, Lawrence A. Leiter, Darren K McGuire, John P.H. Wilding, Marc S. Sabatine

Research output: Contribution to journalArticlepeer-review

176 Scopus citations

Fingerprint Dive into the research topics of 'Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences